Chronic kidney disease and an uncertain diagnosis of Fabry disease: Approach to a correct diagnosis
- 1 February 2015
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 114 (2) , 242-247
Abstract
No abstract availableKeywords
Funding Information
- Dutch Top Institute Pharma (T6-504)
- National Institute for Health Research University College London Hospitals Biomedical Research Centre
- Fondo de Investigaciones Sanitarias—ISCIII (012/0021)
This publication has 28 references indexed in Scilit:
- A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significanceJournal of Medical Genetics, 2013
- Questioning the Pathogenic Role of the GLA p.Ala143Thr “Mutation” in Fabry Disease: Implications for Screening Studies and ERT2012
- Content Validity of the Extended ICF Core Set for Stroke: An International Delphi Survey of Physical TherapistsPhysical Therapy, 2011
- Fabry or not Fabry – a question of ascertainmentEuropean Journal of Human Genetics, 2011
- Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Renal Biopsy Findings in Children and Adolescents With Fabry Disease and Minimal AlbuminuriaAmerican Journal of Kidney Diseases, 2008
- Elevated globotriaosylsphingosine is a hallmark of Fabry diseaseProceedings of the National Academy of Sciences, 2008
- Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implicationsAmerican Journal of Kidney Diseases, 2004
- The frequency of lysosomal storage diseases in The NetherlandsHuman Genetics, 1999
- Prevalence of Lysosomal Storage DisordersJAMA, 1999